CsA |
cyclosporine A |
cTnT |
cardiac troponin T |
FS |
fractional shortening |
hAFSC |
human amniotic fluid-derived stem cell |
hAFSC-iPSC |
human amniotic fluid-derived stem cell induced pluripotent stem cell |
hAFSC-iPSC-CM |
human amniotic fluid-derived stem cell induced pluripotent stem cell derived cardiomyocyte |
hESC |
human embryonic stem cell |
HLA |
human leukocyte antigen |
hPSC |
human pluripotent stem cell |
hPSC-CM |
human pluripotent stem cell derived cardiomyocyte |
I
Ca,L
|
L-type Ca2+ current |
I
Na
|
Na+ current |
iPSC |
induced pluripotent stem cell |
I-R |
ischemia-reperfusion |
LAD |
left anterior descending coronary artery |
LV |
left ventricular |
LVEDD |
left ventricular end-diastolic diameter |
LVEDS |
left ventricular end-diastolic volume |
LVEF |
left ventricular ejection fraction |
LVESD |
left ventricular end-systolic diameter |
LVESV |
left ventricular end-systolic volume |
MHC |
major histocompatibility complex |
MI |
myocardial infarction |
OCT-4 |
octamer-binding transcription factor 4 |
SSEA4 |
Nanog and stage-specific embryonic antigen-4 |